Here is a ground-breaking announcement concerning cervical cancer treatment, released today on ScienceDaily.Com:

Published in the February issue of Clinical Cancer Research, the Phase One study found that a new chemotherapy medicine, Triapine, was well tolerated in combination with standard-of-care cisplatin chemotherapy and radiation treatment in women with cervical cancer. This regimen provided both significant reduction in cancer disease and cancer control.

Read the entire release at New drug combo featuring Triapine shows promise. Don’t forget to temper your hope and enthusiasm by remembering these are only Phase One study results–there is still a long way to go until this treatment combination is proven and FDA approved.
Feel good and keep smiling! Pattie

Leave a Reply